Related references
Note: Only part of the references are listed.Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre
J. A. W. Hagemans et al.
EJSO (2020)
Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer
E. L. K. Voogt et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial.
Geke Hospers et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial
Gianluca Masi et al.
EUROPEAN JOURNAL OF CANCER (2019)
Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer
Karin M. Hardiman et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 28, pg 22, 2017)
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2018)
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO
C. Cremolini et al.
ANNALS OF ONCOLOGY (2018)
Management and prognosis of locally recurrent rectal cancer - A national population-based study
Karin Westberg et al.
EJSO (2018)
Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer
Jinghua Tang et al.
JOURNAL OF CANCER (2018)
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek et al.
JAMA ONCOLOGY (2018)
Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
Xin Yu et al.
CANCER COMMUNICATIONS (2018)
Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer
D. M. G. I. van Zoggel et al.
BRITISH JOURNAL OF SURGERY (2018)
Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial
Danijela Golo et al.
RADIOLOGY AND ONCOLOGY (2018)
Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer
K. Westberg et al.
BRITISH JOURNAL OF SURGERY (2017)
Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres
F. A. Holman et al.
EJSO (2017)
Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment
Miranda Kusters et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Treatment of Locally Recurrent Rectal Carcinoma in Previously (Chemo)Irradiated Patients: A Review
Wout van der Meij et al.
DISEASES OF THE COLON & RECTUM (2016)
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial
C. Fernandez-Martos et al.
ANNALS OF ONCOLOGY (2015)
Early and Late Outcomes of Surgery for Locally Recurrent Rectal Cancer: A Prospective 10-Year Study in the Total Mesorectal Excision Era
Mette Nielsen et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer
Wijnand J. Alberda et al.
DISEASES OF THE COLON & RECTUM (2015)
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Julio Garcia-Aguilar et al.
LANCET ONCOLOGY (2015)
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
Chiara Cremolini et al.
LANCET ONCOLOGY (2015)
Feasibility of reirradiation in the treatment of locally recurrent rectal cancer
S. J. Bosman et al.
BRITISH JOURNAL OF SURGERY (2014)
Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer
Andrea Cercek et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Reirradiation of locally recurrent rectal cancer: A systematic review
Marianne Gronlie Guren et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Preoperative chemoradiation with or without induction oxaliplatin plus 5-fluorouracil in locally advanced rectal cancer
F. A. Calvo et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Chemoradiotherapy response in recurrent rectal cancer
Stanley K. T. Yu et al.
CANCER MEDICINE (2014)
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
R. Marechal et al.
ANNALS OF ONCOLOGY (2012)
Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer
J. V. Schou et al.
ANNALS OF ONCOLOGY (2012)
Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging-Defined, Locally Advanced Rectal Cancer: Grupo Cancer de Recto 3 Study
Carlos Fernandez-Martos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Balancing the efficacy and toxicity of chemotherapy in colorectal cancer
Michael S. Braun et al.
Therapeutic Advances in Medical Oncology (2010)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
RADICALITY OF RESECTION AND SURVIVAL AFTER MULTIMODALITY TREATMENT IS INFLUENCED BY SUBSITE OF LOCALLY RECURRENT RECTAL CANCER
Miranda Kusters et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer
Raphaela C. Dresen et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials
Hendrik-Tobias Arkenau et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest
Alfredo Falcone et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surgery for local recurrence of rectal cancer
A. G. Heriot et al.
COLORECTAL DISEASE (2006)
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC):: a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
J Souglakos et al.
BRITISH JOURNAL OF CANCER (2006)
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study
V Valentini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer
I Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy
M van den Brink et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
E Kapiteijn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The impact of recurrent rectal cancer on quality of life
J Camilleri-Brennan et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Share Paper
